My research focuses on dissecting the molecular pathways underlying the pathology of liver disease associated with genetic disorders by combining 3D models and in vivo studies. TIGEM offers unique expertise and excellent resources to pursue my goal.
- AIRC - Tackling the biological complexity of HCC development in Alpha-1 antitrypsin deficiency (2023-2024)
- ALP, ALPHA1-FOUNDATION - Identification and modulation of local and systemic environmental factors in AATD (2022-2024)
- ALP, ALPHA1-FOUNDATION - Investigating the effects of mutant a1 antitrypsin on liver cell fate and HCC development (2021-2023)